Evolution of health care utilization and expenditure during the year before death in 2015 among people with cancer : French snds-based cohort study

Article indépendant

TANGUY-MELAC, Audrey | VERBOUX, Dorian | PESTEL, Laurence | FAGOT-CAMPAGNA, Anne | TUPPIN, Philippe | GASTALDI-MÉNAGER, Christelle

BACKGROUND: Cancer patients have one of the highest health care expenditures (HCE) at the end of life. However, the growth of HCE at the end of life remains poorly documented in the literature. OBJECTIVE: To describe monthly reimbursed expenditure during the last year of life among cancer patients, by performing detailed analysis according to type of expenditure and the person's age. METHOD: Data were derived from the Système national des données en santé (SNDS) [national health data system], which comprises information on ambulatory and hospital care. Analyses focused on general scheme beneficiaries (77% of the French population) treated for cancer who died in 2015. RESULTS: Average reimbursed expenditure during the last year of life was €34,300 per person in 2015, including €21,100 (62%) for hospital expenditure. "Short-stays hospital" and "rehabilitation units" stays expenditure were €14,700 and €2000, respectively. Monthly expenditure increased regularly towards the end of life, increasing from 12 months before death €2000 to €5200 1 month before death. The highest levels of expenditure did not concern the oldest people, as average reimbursed expenditure was €50,300 for people 18-59 years versus €25,600 for people 80-90 years. Out-of-pocket payments varied only slightly according to age, but increased towards the end of life. CONCLUSION: A marked growth of HCE was observed during the last 4 months of life, mainly driven by hospital expenditure, with a more marked growth for younger people.

http://dx.doi.org/10.1007/s10198-021-01304-1

Voir la revue «THE EUROPEAN JOURNAL OF HEALTH ECONOMICS»

Autres numéros de la revue «THE EUROPEAN JOURNAL OF HEALTH ECONOMICS»

Consulter en ligne

Suggestions

Du même auteur

Evolution of health care utilization and expe...

Article | TANGUY-MELAC, Audrey | THE EUROPEAN JOURNAL OF HEALTH ECONOMICS

BACKGROUND: Cancer patients have one of the highest health care expenditures (HCE) at the end of life. However, the growth of HCE at the end of life remains poorly documented in the literature. OBJECTIVE: To describe monthly reimb...

Evolution of health care utilization and expe...

Article indépendant | TANGUY-MELAC, Audrey | THE EUROPEAN JOURNAL OF HEALTH ECONOMICS

BACKGROUND: Cancer patients have one of the highest health care expenditures (HCE) at the end of life. However, the growth of HCE at the end of life remains poorly documented in the literature. OBJECTIVE: To describe monthly reimb...

Intensity of care, expenditure, place and cau...

Article | TANGUY-MELAC, Audrey | Bulletin du cancer | n°3 | vol.107

INTRODUCTION: Health care utilization of people with lung cancer (LC) the last year of life, their causes of death and place of death and the associated expenditure have been poorly described together. Then we conducted an observa...

De la même série

The cost of frailty in France

Article indépendant | SIRVEN, Nicolas | THE EUROPEAN JOURNAL OF HEALTH ECONOMICS | n°2 | vol.18

The objective of the present work is to explore the incremental costs of frailty associated with ambulatory health care expenditures (HCE) among the French population of community-dwellers aged 65 or more in 2012. We make use of a...

Integrating specialist palliative care to imp...

Article indépendant | LOWERS, Jane | BMJ open respiratory research | n°1 | vol.9

Introduction: Cystic fibrosis (CF) is a life-limiting genetic disorder estimated to affect more than 160 000 individuals and their families worldwide. People living with CF commonly experience significant physical and emotional sy...

Specialist palliative care, psychology, inter...

Article indépendant | BARRATT, Shaney L. | BMJ open respiratory research | n°1 | vol.5

Introduction: Patients with progressive idiopathic fibrotic interstitial lung disease (ILD), such as those with idiopathic pulmonary fibrosis (IPF), can have an aggressive disease course, with a median survival of only 3-5 years f...

German tariffs for the ICECAP-supportive care...

Article indépendant | DAMS, Judith | THE EUROPEAN JOURNAL OF HEALTH ECONOMICS

OBJECTIVES: Economic evaluations often use preference-based value sets (tariffs) for health-related quality of life to quantify health effects. For wellbeing at the end of life, issues beyond health-related quality of life may be ...

Evolution of health care utilization and expe...

Article indépendant | TANGUY-MELAC, Audrey | THE EUROPEAN JOURNAL OF HEALTH ECONOMICS

BACKGROUND: Cancer patients have one of the highest health care expenditures (HCE) at the end of life. However, the growth of HCE at the end of life remains poorly documented in the literature. OBJECTIVE: To describe monthly reimb...

Chargement des enrichissements...